From Odyssey to Answers: How Progeny Helps Improve Rare Disease Care

Three Benefits of Ordering Exome Testing as Trios

Why Consider an Exome-First Testing Workflow?
Post Image

April 2025 Hereditary Cancer Menu and Reporting Updates
  • Lauren Csukardi
  • April 22, 2025

At Ambry, we’re continuing our track record of scientific innovation and discoveries with our latest hereditary cancer testing menu enhancements and reporting updates—powered by Ambry Classifi®. Our peer-reviewed, published gene-disease validity (GDV) scheme enables the enhanced assessment and characterization of RPS20 for colorectal …

Read More
Post Image

From Good to Great: Continuous Improvement of Our High-Risk Women's Program

  • April 9, 2025
Post Image

From Odyssey to Answers: How Progeny Helps Improve Rare Disease Care

  • February 28, 2025
Post Image

Three Benefits of Ordering Exome Testing as Trios

  • February 19, 2025
Post Image

Why Consider an Exome-First Testing Workflow?

  • February 4, 2025
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience
  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More
Post Image

Navigating NF1: The Moss Family’s Story of Resilience and Hope

  • May 16, 2024
Post Image

Transforming Fear into Action and Advocacy: Our Family’s Lynch Syndrome Story

  • March 22, 2024
Post Image

Peace of Mind: Michelle Majewski Trusts the Patient for Life Program to Share Answers for Her Son Owen

  • November 14, 2023
Post Image

Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week

  • June 14, 2023

Subscribe

Subscribe to our blog for updates, sent out every month.

Tags